carvedilol has been researched along with deoxyglucose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, O; Farhat, R; Fisher, SJ; Knight, N; Sejling, AS; Su, G | 1 |
| Benally, T; Chan, O; de Santana-Van Vliet, E; Farhat, R; Neely, L; Su, G | 1 |
2 other study(ies) available for carvedilol and deoxyglucose
| Article | Year |
|---|---|
Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Blood Glucose; Body Weight; Carvedilol; Catheterization; Deoxyglucose; Disease Models, Animal; Glucose Clamp Technique; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Lactic Acid; Male; Rats; Rats, Sprague-Dawley; Recurrence; Time Factors; Ventromedial Hypothalamic Nucleus | 2019 |
Carvedilol prevents impairment of the counterregulatory response in recurrently hypoglycaemic diabetic rats.
Topics: Adrenergic beta-Antagonists; Animals; Awareness; Carvedilol; Deoxyglucose; Diabetes Mellitus, Experimental; Hypoglycemia; Male; Rats, Sprague-Dawley; Recurrence; Streptozocin | 2021 |